^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Miyagi Y, Koshikawa N, Yasumitsu H, Miyagi E, Hirahara F, Aoki I, Misugi K, Umeda M, Miyazaki K (Apr 1995). "cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2". J Biochem. 116 (5): 939–42. doi:10.1093/oxfordjournals.jbchem.a124648. PMID7896752.
^Miyagi Y, Yasumitsu H, Mizushima H, Koshikawa N, Matsuda Y, Itoh H, Hori TA, Aoki I, Misugi K, Miyazaki K (Jan 1997). "Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6". DNA Cell Biol. 15 (11): 947–54. doi:10.1089/dna.1996.15.947. PMID8945635.
Bützow R, Huhtala ML, Bohn H, et al. (1988). "Purification and characterization of placental protein 5". Biochem. Biophys. Res. Commun. 150 (1): 483–90. doi:10.1016/0006-291X(88)90546-3. PMID3276312.
Takayama M, Soma H, Saito T, et al. (1983). "Circulating levels of placental protein 5 in normal and abnormal pregnancies". Gynecol. Obstet. Invest. 16 (1): 13–26. doi:10.1159/000299207. PMID6884838.
Petersen LC, Sprecher CA, Foster DC, et al. (1996). "Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor". Biochemistry. 35 (1): 266–72. doi:10.1021/bi951501d. PMID8555184.
Miyagi Y, Yasumitsu H, Eki T, et al. (1996). "Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis". Genomics. 35 (1): 267–8. doi:10.1006/geno.1996.0353. PMID8661135.
Udagawa K, Miyagi Y, Hirahara F, et al. (1998). "Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization". Placenta. 19 (2–3): 217–23. doi:10.1016/S0143-4004(98)90011-X. PMID9548189.
Liu Y, Stack SM, Lakka SS, et al. (1999). "Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin". Arch. Biochem. Biophys. 370 (1): 112–8. doi:10.1006/abbi.1999.1371. PMID10496984.
Kamei S, Kazama Y, Kuijper JL, et al. (2001). "Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene". Biochim. Biophys. Acta. 1517 (3): 430–5. doi:10.1016/S0167-4781(00)00298-0. PMID11342222.
Udagawa K, Yasumitsu H, Esaki M, et al. (2002). "Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts". Placenta. 23 (2–3): 145–53. doi:10.1053/plac.2001.0774. PMID11945080.
Rao CN, Segawa T, Navari JR, et al. (2003). "Methylation of TFPI-2 gene is not the sole cause of its silencing". Int. J. Oncol. 22 (4): 843–8. doi:10.3892/ijo.22.4.843. PMID12632077.